Renhe Pharmacy Co., Ltd. (000650.SZ)
CNY 5.93
(-0.17%)
CNY 5.93
(-0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.03 Billion | 5.15 Billion | 4.93 Billion | 4.1 Billion | 4.58 Billion | 4.4 Billion |
| Cost of Revenue | 3.22 Billion | 3.26 Billion | 3.06 Billion | 2.45 Billion | 2.64 Billion | 2.51 Billion |
| Gross Profit | 1.8 Billion | 1.88 Billion | 1.87 Billion | 1.65 Billion | 1.93 Billion | 1.89 Billion |
| Operating Expenses | 946.19 Million | 947.33 Million | 929.94 Million | 864.25 Million | 1.12 Billion | 1.13 Billion |
| Selling, General and Administrative Expenses | 808.63 Million | 627.17 Million | 652.99 Million | 630.01 Million | 867.26 Million | 863.74 Million |
| Research and Development Expenses | 76.98 Million | 50.53 Million | 52.14 Million | 39.79 Million | 38.04 Million | 31.07 Million |
| Other Expenses | 60.57 Million | 269.62 Million | 224.8 Million | 194.45 Million | 219.58 Million | 2.43 Million |
| Cost and Expenses | 4.13 Billion | 4.21 Billion | 3.99 Billion | 3.32 Billion | 3.76 Billion | 3.64 Billion |
| Operating Income | 898.63 Million | 953.26 Million | 1.03 Billion | 860.51 Million | 826.17 Million | 752.86 Million |
| Interest Expense | 3.73 Million | 427.6 Thousand | 978.57 Thousand | 1.41 Million | 50.28 Thousand | 528.19 Thousand |
| Income Tax Expense | 269.44 Million | 241.98 Million | 234.54 Million | 189.96 Million | 204.57 Million | 171.21 Million |
| Earnings before Tax | 898.86 Million | 953.53 Million | 1.03 Billion | 847.61 Million | 823.87 Million | 755.3 Million |
| Net Income | 567.25 Million | 574.43 Million | 665.02 Million | 580.18 Million | 537.82 Million | 506.46 Million |
| Earnings Per Share Basic | 0.41 | 0.41 | 0.48 | 0.46 | 0.43 | 0.41 |
| Earnings Per Share Diluted | 0.41 | 0.41 | 0.48 | 0.46 | 0.43 | 0.41 |
| Weighted Average Shares Outstanding | 1.38 Billion | 1.39 Billion | 1.39 Billion | 1.26 Billion | 1.23 Billion | 1.23 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.38 Billion | 1.39 Billion | 1.39 Billion | 1.26 Billion | 1.23 Billion | 1.23 Billion |
| Gross Margin | 0.36 | 0.37 | 0.38 | 0.40 | 0.42 | 0.43 |
| EBIT Margin | 0.21 | 0.22 | 0.23 | 0.23 | 0.20 | 0.20 |
| Profit Margin | 0.11 | 0.11 | 0.13 | 0.14 | 0.12 | 0.12 |
| EBITDA | 1.05 Billion | 1.07 Billion | 1.12 Billion | 967.74 Million | 911.97 Million | 851.19 Million |
| Earnings Before Tax Margin | 0.18 | 0.18 | 0.21 | 0.21 | 0.18 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 776.27 Million | 1.11 Billion | 1.22 Billion | 4.98 Billion | 1.2 Billion | 1.13 Billion |
| Cost of Revenue | 507.07 Million | 687.07 Million | 783.89 Million | 3.22 Billion | 803.31 Million | 702.6 Million |
| Gross Profit | 269.2 Million | 428.07 Million | 442.12 Million | 1.75 Billion | 397.19 Million | 434.16 Million |
| Operating Expenses | 161.26 Million | 166.95 Million | 268.25 Million | 815.97 Million | 396.13 Million | 181.96 Million |
| Selling, General and Administrative Expenses | 155.8 Million | 156.02 Million | 261.79 Million | - | 156.11 Million | 305.6 Million |
| Research and Development Expenses | 5.67 Million | 10.53 Million | 6.46 Million | - | 16.9 Million | 7.55 Million |
| Other Expenses | 213.77 Thousand | -398.79 Thousand | -460.74 Thousand | -15.19 Million | -223.11 Million | 515 Thousand |
| Cost and Expenses | 668.34 Million | 854.03 Million | 1.05 Billion | 4.03 Billion | 1.19 Billion | 884.57 Million |
| Operating Income | 107.93 Million | 261.11 Million | 173.86 Million | 943.03 Million | 1.06 Million | 297.08 Million |
| Interest Expense | 16.02 Thousand | 31.9 Thousand | 47.64 Thousand | 345.1 Thousand | 63.23 Thousand | 78.68 Thousand |
| Income Tax Expense | 39.46 Million | 74.39 Million | 54.6 Million | 269.44 Million | 63.3 Million | 73.26 Million |
| Earnings before Tax | 142.96 Million | 277.3 Million | 264.39 Million | 899.77 Million | 41.04 Million | 297.59 Million |
| Net Income | 78.5 Million | 159.87 Million | 177.29 Million | 567.25 Million | 26.88 Million | 183.82 Million |
| Earnings Per Share Basic | 0.06 | 0.12 | 0.13 | - | 0.02 | 0.13 |
| Earnings Per Share Diluted | 0.06 | 0.12 | 0.13 | - | 0.02 | 0.13 |
| Weighted Average Shares Outstanding | 1.38 Billion | 1.38 Billion | 1.38 Billion | 1.39 Billion | 1.39 Billion | 1.39 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.38 Billion | 1.38 Billion | 1.38 Billion | 1.39 Billion | 1.39 Billion | 1.39 Billion |
| Gross Margin | 0.35 | 0.38 | 0.36 | 0.35 | 0.33 | 0.38 |
| EBIT Margin | 0.18 | 0.26 | 0.22 | - | 0.03 | 0.26 |
| Profit Margin | 0.10 | 0.14 | 0.14 | 0.11 | 0.02 | 0.16 |
| EBITDA | 142.98 Million | 289.68 Million | 265.45 Million | - | 38.05 Million | 299.44 Million |
| Earnings Before Tax Margin | 0.14 | 0.23 | 0.14 | 0.19 | 0.00 | 0.26 |
MAFATIND
1330
SOHO
SSII
282330
EZJ